SCHEMBL7309594

SCHEMBL7309594

COc1ccc2c(c1)c(=O)[nH]c(=O)n2CCCCN1CCN(c2ccccc2OC)CC1

nearest known ligand 0.68

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 13/20 0.68
HTR1A P08908 8/20 0.65
ADRA2A P08913 2/20 0.57
ADRA2B P18089 2/20 0.57
ADRB2 P07550 1/20 0.57
ADRA2C P18825 1/20 0.57
ADRA1D P25100 1/20 0.56
ADRA1A P35348 1/20 0.56
ADRA1B P35368 1/20 0.56
DRD2 P14416 2/20 0.55
DRD3 P35462 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7298673 0.91 HTR1A (0.56) HTR7HTR1AADRA1DADRA1AADRA1B
SCHEMBL7300518 0.89 HTR7 (0.77) HTR7HTR1AADRA2AADRA2BADRB2
SCHEMBL8943310 0.87 HTR7 (0.81) HTR7HTR1AADRA2AADRA2BADRB2
SCHEMBL7300725 0.84 HTR7 (0.67) HTR7HTR1AADRA2AADRA2BADRB2
SCHEMBL8131304 0.81 HTR7 (1.00) HTR7HTR1AADRA2AADRA2BADRB2
SCHEMBL7301822 0.80 HTR1A (0.63) HTR7HTR1AADRA2AADRA2BADRB2
SCHEMBL8125943 0.80 HTR7 (0.81) HTR7HTR1AADRA2AADRA2BADRB2
SCHEMBL10637877 0.80 ADRA2A (0.81) HTR7HTR1AADRA2AADRA2BADRA1D
SCHEMBL8128438 0.79 HTR7 (1.00) HTR7HTR1AADRA2AADRA2BADRB2
SCHEMBL8136613 0.79 HTR7 (0.76) HTR7HTR1AADRA2AADRA2BADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed